Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells (Q38891984)

7 September 2017

Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells (English)

1 reference

7 September 2017

7

Lyndi M Rice

1 reference

7 September 2017

Rajash Pallai

1

1 reference

7 September 2017

Aishwarya Bhaskar

2

1 reference

7 September 2017

Natalie Barnett-Bernodat

3

1 reference

7 September 2017

Christina Gallo-Ebert

4

1 reference

7 September 2017

Michelle Pusey

5

1 reference

7 September 2017

Joseph T Nickels

6

1 reference

7 September 2017

2 April 2015

1 reference

7 September 2017

1 reference

7 September 2017

36

1 reference

7 September 2017

8

1 reference

7 September 2017

6383-6390

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-3326-1

7 September 2017

0 references

cites work

PP2A: unveiling a reluctant tumor suppressor

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Multiple pathways regulated by the tumor suppressor PP2A in transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Circumventing cellular control of PP2A by methylation promotes transformation in an Akt-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Clk2 and B56β mediate insulin-regulated assembly of the PP2A phosphatase holoenzyme complex on Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

B55alpha PP2A holoenzymes modulate the phosphorylation status of the retinoblastoma-related protein p107 and its activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

HEAT repeat 1 motif is required for B56γ-containing protein phosphatase 2A (B56γ-PP2A) holoenzyme assembly and tumor-suppressive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

ATM-mediated phosphorylation activates the tumor-suppressive function of B56γ-PP2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Identification of PP2A complexes and pathways involved in cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A inhibits PP2A in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A expression is increased in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Prognostic role of CIP2A expression in serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A is a predictor of poor prognosis in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Cancerous inhibitor of protein phosphatase 2A mediates bortezomib-induced autophagy in hepatocellular carcinoma independent of proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Mechanisms of MYC stabilization in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A modulates cell-cycle progression in human cancer cells by regulating the stability and activity of Plk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Nuclear import of exogenous FGF1 requires the ER-protein LRRC59 and the importins Kpnα1 and Kpnβ1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A is associated with human breast cancer aggressivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Clinical implications of CIP2A protein expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Novel fusion transcripts associate with progressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A protein expression in high-grade, high-stage bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A expression and localization in oral carcinoma and dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Increased expression of CIP2A in aggressive subtypes of B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A expression and prognostic role in patients with esophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A is overexpressed and involved in the pathogenesis of chronic myelocytic leukemia by interacting with breakpoint cluster region-Abelson leukemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A overexpression is associated with c-Myc expression in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A is a target of bortezomib in human triple negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Protein-protein interaction inhibitors: small molecules from screening techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Cancerous inhibitor of protein phosphatase 2A promotes premature chromosome segregation and aneuploidy in prostate cancer cells through association with shugoshin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

CIP2A promotes proliferation of spermatogonial progenitor cells and spermatogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3326-1

Protein phosphatase 2A regulatory subunits and cancer.

21 January 2018

1 reference

12 December 2020

Crosstalk and signaling switches in mitogen-activated protein kinase cascades

1 reference

12 December 2020

PME-1 modulates protein phosphatase 2A activity to promote the malignant phenotype of endometrial cancer cells

1 reference

12 December 2020

Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics

1 reference

12 December 2020

CIP2A facilitates apoptotic resistance of fibroblast-like synoviocytes in rheumatoid arthritis independent of c-Myc expression

1 reference

12 December 2020

Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize metastatic castration-resistant prostate cancer cells to cabazitaxel chemotherapy

1 reference

12 December 2020

10.1007/S13277-015-3326-1

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

0 references

1 reference